Jazz Pharmaceuticals plc’s recent filing unveils that its Chairman & CEO COZADD BRUCE C unloaded Company’s shares for reported $0.11 million on Jul 01 ’25. In the deal valued at $107.63 per share,1,000 shares were sold. As a result of this transaction, COZADD BRUCE C now holds 436,973 shares worth roughly $50.84 million.
Then, COZADD BRUCE C bought 1,000 shares, generating $107,630 in total proceeds.
Before that, COZADD BRUCE C sold 500 shares. Jazz Pharmaceuticals plc shares valued at $55,000 were divested by the Chairman & CEO at a price of $110.00 per share. As a result of the transaction, COZADD BRUCE C now holds 437,973 shares, worth roughly $50.95 million.
Deutsche Bank initiated its Jazz Pharmaceuticals plc [JAZZ] rating to a Buy in a research note published on July 15, 2025; the price target was $152. A number of analysts have revised their coverage, including UBS’s analysts, who increased its forecast for the stock in early March from “a Neutral” to “a Buy”. Cantor Fitzgerald also remained covering JAZZ and has decreased its forecast on February 26, 2025 with a “Neutral” recommendation from previously “an Overweight” rating. Wells Fargo revised its rating on February 13, 2025. It rated JAZZ as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of JAZZ
On Tuesday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock jump 3.28% to $116.34. Over the last five days, the stock has gained 3.60%. Jazz Pharmaceuticals plc shares have risen nearly 6.89% since the year began. Nevertheless, the stocks have fallen -5.53% over the past one year. While a 52-week high of $148.06 was reached on 02/26/25, a 52-week low of $95.49 was recorded on 04/09/25.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 112.75, which if violated will result in even more drops to 109.16. On the upside, there is a resistance level at 118.38. A further resistance level may holdings at 120.42.
How much short interest is there in Jazz Pharmaceuticals plc?
A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on 2025-06-30, growing by 0.16 million shares to a total of 5.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-30 was 5.71 million shares. There was a rise of 2.65%, which implies that there is a positive sentiment for the stock.
